Several studies have shown in patients magnesium deficiency with liver cirrhosis.
and muscle magnesium.
"Interestingly, zinc also blocks the inflammatory activity of IFN-λ3, which has
been strongly linked to accelerated progression to liver cirrhosis
in viral and non-viral liver disease.
“有趣的是,鋅還可以阻斷IFN-λ3的炎症活動,這與病毒性和非病毒性肝病
中加速進展為肝硬化密切相關。
"Our data suggests that serum zinc levels in patients with
chronic hepatitis C are genetically predetermined by the IFN-λ3
polymorphism, confirming the inhibitory role of zinc in vivo.
“我們的數據表明慢性丙型肝炎患者的血清鋅水平在遺傳上由IFN-λ3多態性預先確定
,證實了鋅在體內的抑製作用。
Poor zinc status is common in cirrhosis.
鋅的狀況不佳在肝硬化中很常見。
At baseline, serum zinc was low normal or reduced, and returned
to normal range in all patients after supplementation.
Liver function improved significantly.
在基線時,血清鋅低正常或降低,並在補充後在所有患者中恢復到正常範圍。
肝功能明顯改善。
The study confirms that oral zinc produces metabolic effects in zinc-deficient
patients with cirrhosis.
該研究證實,口服鋅可使缺鋅的肝硬化患者產生代謝作用。
50 were healthy subjects and 50adult hospitalised cirrhotic patients
were selected purposively for the study according toselection crieteria.
其中50名為健康受試者,50名住院的肝硬化患者根據選擇性目的選擇用於研究。
Serum zinc level was found to be low in 72% patients.
72%的患者血清鋅水平較低。
In cirrhotic patients serum zinc level was significantly lower than that
of healthy controls (P<0.001).
在肝硬化患者中,血清鋅水平顯著低於健康對照組(P <0.001)。